The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list…Read More
Author Archives: Erasmo Motsinger
The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S. Food and Drug Administration (FDA).Read more…Read More
The real cost? Your medical license…Read More
Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these figures provides insight into the shifting landscape of the pharmaceutical industry, including the rise of weight-loss drugs, the shrinking demand of COVID-19 vaccines, and the necessity of…Read more…Read More
In 2024, Selena Gomez has been in the spotlight for proudly embracing her curves while managing her autoimmune condition, Lupus. However, recent changes have caught attention. In her latest red carpet appearances, the 32-year-old surprised everyone with a noticeably slimmer look, which quickly led to fans speculating about possible Ozempic use…Read More
Ok Halloween… you can start now,” the pop-rap star wrote on social media…Read More
GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according to a new analysis of U.S. health insurance claims.Read more…Read More
A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing Alzheimer’s disease…Read More
Viking Therapeutics (VKTX) is one of several pharma companies racing to break up the weight loss drug duopoly currently held by Ozempic-maker Novo Nordisk (NVO) and Eli Lilly (LLY), the producer of Zepbound. Read more…Read More
Ice Spice is currently on her “Y2K! World Tour,” but that evidently hasn’t kept her out of the gym. On Thursday (Aug. 29) night, the Bronx native dropped her official fitness routine.Continue reading……Read More
- 1
- 2